ABT
WAITAbbott Laboratories
$105.70
+0.09%delayed
News – · Trend ▲ · inside triggers –
Expected move (1d)
▼ $102.60to$108.80 ▲
ATR ±$3.10 (+2.93%)Implied ±$3.38 (+3.19%)
Entry Reference
Price / prev close$105.70 / $105.61
Day range$102.89 – $106.39
52-wk range$81.97 – $137.49(43%)
Volume vs avg0.73×
ATR (14d)$3.10
MA 8 / 21$104.43 / $98.91
MA 50 / 200$93.30 / $108.35
Call ▲ / Put ▼ trigger$106.34 / $104.88
+1 / +2 ATR$108.80 / $111.90
-1 / -2 ATR$102.60 / $99.50
Support: 103.84 100.88 98.14
Resistance: 111.18 116.82
Near-the-money contracts
exp 2026-08-07Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 103 | $3.42 | 44% | 0.70 | -0.19 | 50 |
| 104 | $2.80 | 41% | 0.64 | -0.18 | 65 |
| 105 | $2.02 | 37% | 0.57 | -0.17 | 286 |
| 106 | $1.15 | 39% | 0.49 | -0.19 | 169 |
| 107 | $1.15 | 36% | 0.41 | -0.17 | 213 |
| 108 | $0.57 | 32% | 0.31 | -0.13 | 142 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 102 | $0.38 | 32% | -0.18 | -0.09 | 51 |
| 104 | $0.88 | 32% | -0.33 | -0.13 | 73 |
| 105 | $0.82 | 31% | -0.42 | -0.14 | 76 |
| 106 | $2.23 | 49% | -0.50 | -0.22 | 118 |
| 107 | $2.90 | 55% | -0.55 | -0.24 | 32 |
| 110 | $4.40 | 37% | -0.79 | -0.11 | 39 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?1d ago
- Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook1d ago
- AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue1d ago
- Guardant Health, Stock Of The Day, Offers Entry With Earnings Due2d ago
- Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors3d ago
- Best Dividend Aristocrats For August 20263d ago
- 3 Dividend Stocks to Buy for a Lifetime of Passive Income3d ago
- AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?3d ago
- Abbott starts TriClip study amid rising competition for heart valve repair4d ago
- These 3 Companies Reported Record Results and Raised Guidance4d ago
- [Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)4d ago
- AllianceBernstein Q2 Earnings Call Highlights4d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.